Literature DB >> 25083241

Diuretic drugs benefit patients with hypertension more with night-time dosing.

Basil N Okeahialam1, Esther N Ohihoin2, Jayne Na Ajuluchukwu3.   

Abstract

OBJECTIVES: Night-time chronotherapy in antihypertensive drugs has been shown to produce better blood pressure control and protect from cardiovascular morbidity and mortality. To date, this has been proven for several drug classes excluding thiazides diuretics. Given the peculiar response of blood pressure to thiazides in black people we sought to determine whether night-time chronotherapy with thiazides produces better control as already shown with other drug classes.
METHODS: A subanalysis of a larger chronotherapy study with antihypertensive drugs in Nigerian Africans was done. The subpopulation of those whose disease was controlled after 12 weeks of diuretic monotherapy was analysed. Those who received drugs in the morning and at night were compared along control lines and some cardiac indices.
RESULTS: Both groups were similar on all scores at baseline. After 12 weeks of monotherapy patients who received drugs at night had significantly lower systolic and diastolic blood pressure though control was achieved with both morning and night-time dosing. Also the left ventricular posterior and septal walls regressed better as well as left ventricular mass in the night-time group.
CONCLUSION: Though equally effective in reducing blood pressure and cardiac indices related to hypertension, patients taking their drugs at night recorded better values. This makes diuretics equally amenable to night-time chronotherapy as other drug classes. This effect should be explored to reduce the morbidity and mortality consequences of hypertension.

Entities:  

Keywords:  Africans; benefit; night-time therapy; thiazide diuretics

Year:  2012        PMID: 25083241      PMCID: PMC4110843          DOI: 10.1177/2042098612459537

Source DB:  PubMed          Journal:  Ther Adv Drug Saf        ISSN: 2042-0986


  19 in total

1.  Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.

Authors:  B M Psaty; N L Smith; D S Siscovick; T D Koepsell; N S Weiss; S R Heckbert; R N Lemaitre; E H Wagner; C D Furberg
Journal:  JAMA       Date:  1997-03-05       Impact factor: 56.272

2.  Hypertension improvement project: randomized trial of quality improvement for physicians and lifestyle modification for patients.

Authors:  Laura P Svetkey; Kathryn I Pollak; William S Yancy; Rowena J Dolor; Bryan C Batch; Greg Samsa; David B Matchar; Pao-Hwa Lin
Journal:  Hypertension       Date:  2009-12       Impact factor: 10.190

3.  Circadian variation in the timing of stroke onset: a meta-analysis.

Authors:  W J Elliott
Journal:  Stroke       Date:  1998-05       Impact factor: 7.914

4.  Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.

Authors:  Ramón C Hermida; Diana E Ayala; Artemio Mojón; María J Fontao; José R Fernández
Journal:  Chronobiol Int       Date:  2011-08-08       Impact factor: 2.877

5.  Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study.

Authors:  Ramón C Hermida; Diana E Ayala; Artemio Mojón; José R Fernández
Journal:  Chronobiol Int       Date:  2010-09       Impact factor: 2.877

6.  [Hypertensive disease in subjects born in sub-Saharan Africa or in Europe referred to a hypertension unit: a cross-sectional study].

Authors:  Thierry Gombet; Olivier Steichen; Pierre-François Plouin
Journal:  Bull Acad Natl Med       Date:  2007-11       Impact factor: 0.144

7.  Impaired diurnal blood pressure variation and all-cause mortality.

Authors:  Daniel J Brotman; Michael B Davidson; Mirna Boumitri; Donald G Vidt
Journal:  Am J Hypertens       Date:  2008-01       Impact factor: 2.689

8.  Different drug classes have variable effects on blood pressure depending on the time of day.

Authors:  Trefor O Morgan; Adrianne Anderson
Journal:  Am J Hypertens       Date:  2003-01       Impact factor: 2.689

Review 9.  Chronotherapy of hypertension.

Authors:  Ramón C Hermida; Michael H Smolensky
Journal:  Curr Opin Nephrol Hypertens       Date:  2004-09       Impact factor: 2.894

Review 10.  First-line drugs for hypertension.

Authors:  James M Wright; Vijaya M Musini
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08
View more
  4 in total

Review 1.  Chronotherapy for Hypertension.

Authors:  N P Bowles; S S Thosar; M X Herzig; S A Shea
Journal:  Curr Hypertens Rep       Date:  2018-09-28       Impact factor: 5.369

2.  One-size-fits-all management of hypertension: a key to poor control of hypertension in low income settings in sub-Saharan Africa?

Authors:  Ahmadou M Jingi; Jean Jacques N Noubiap; Clovis Nkoke
Journal:  Ann Transl Med       Date:  2016-11

3.  Greater natriuretic response to ENaC inhibition in male versus female Sprague-Dawley rats.

Authors:  Reham H Soliman; Jermaine G Johnston; Eman Y Gohar; Crystal M Taylor; David M Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-01-08       Impact factor: 3.619

Review 4.  Translating around the clock: Multi-level regulation of post-transcriptional processes by the circadian clock.

Authors:  Amber A Parnell; Aliza K De Nobrega; Lisa C Lyons
Journal:  Cell Signal       Date:  2020-12-25       Impact factor: 4.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.